Initiation and Titration of Amaryl
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.
Also called NCT01144728
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 172 participants
- Sponsor
- Registry
-
NCT01144728
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Kazakhstan
- Registry status
- Completed
Technical summary
Registry record NCT01144728. Allocation not applicable; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2010-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Initiation and Titration of Amaryl
- Acronym
- AMIT KZ
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- GLIMEPIRIDE + METFORMIN
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01144728- Content hash
7c5ce01fd7c2eaedf3b635d24ff3d2cfc4284df4f64f96072e3c6bd4095176c6